[go: up one dir, main page]

DK3448416T3 - Semaglutid ved kardiovaskulære tilstande - Google Patents

Semaglutid ved kardiovaskulære tilstande Download PDF

Info

Publication number
DK3448416T3
DK3448416T3 DK17721109.1T DK17721109T DK3448416T3 DK 3448416 T3 DK3448416 T3 DK 3448416T3 DK 17721109 T DK17721109 T DK 17721109T DK 3448416 T3 DK3448416 T3 DK 3448416T3
Authority
DK
Denmark
Prior art keywords
semaglutid
cardiovascular conditions
cardiovascular
conditions
Prior art date
Application number
DK17721109.1T
Other languages
English (en)
Inventor
Oluf Kristian Højbjerg Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58668875&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3448416(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK3448416T3 publication Critical patent/DK3448416T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
DK17721109.1T 2016-04-28 2017-04-28 Semaglutid ved kardiovaskulære tilstande DK3448416T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16167458 2016-04-28
EP16188262 2016-09-12
PCT/EP2017/060160 WO2017186896A1 (en) 2016-04-28 2017-04-28 Semaglutide in cardiovascular conditions

Publications (1)

Publication Number Publication Date
DK3448416T3 true DK3448416T3 (da) 2022-10-03

Family

ID=58668875

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17721109.1T DK3448416T3 (da) 2016-04-28 2017-04-28 Semaglutid ved kardiovaskulære tilstande

Country Status (23)

Country Link
US (1) US20190134162A1 (da)
EP (1) EP3448416B1 (da)
JP (1) JP7221694B2 (da)
KR (3) KR102778218B1 (da)
CN (1) CN109069589B (da)
AU (2) AU2017256774B2 (da)
BR (1) BR112018072020A2 (da)
CA (1) CA3022535A1 (da)
CL (1) CL2018003045A1 (da)
DK (1) DK3448416T3 (da)
ES (1) ES2928007T3 (da)
HR (1) HRP20221150T1 (da)
HU (1) HUE060040T2 (da)
IL (1) IL262390B1 (da)
MA (1) MA44762A (da)
MX (1) MX2018012700A (da)
MY (1) MY202967A (da)
PH (1) PH12018502274B1 (da)
PL (1) PL3448416T3 (da)
RS (1) RS63630B1 (da)
RU (1) RU2768283C2 (da)
SI (1) SI3448416T1 (da)
WO (1) WO2017186896A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7221694B2 (ja) 2016-04-28 2023-02-14 ノヴォ ノルディスク アー／エス 心血管状態におけるセマグルチド
ES2976496T3 (es) 2017-08-24 2024-08-02 Novo Nordisk As Composiciones de GLP-1 y usos de las mismas
US20210379159A1 (en) * 2018-10-26 2021-12-09 Novo Nordisk A/S Stable semaglutide compositions and uses thereof
US11617965B2 (en) 2018-12-21 2023-04-04 Novo Nordisk A/S Process of spray drying of GLP-1 peptide
US20230082544A1 (en) * 2020-02-18 2023-03-16 Novo Nordisk A/S Pharmaceutical formulations
CN114699510B (zh) * 2021-12-29 2024-07-16 浙江湃肽生物有限公司 一种司美格鲁肽微针阵列及其制备方法
AU2023285400A1 (en) * 2022-06-08 2024-12-05 Zydus Lifesciences Limited Reusable multi-dose, variable dose, single pen injector for type 2 diabetes and weight management
CN117462654A (zh) * 2023-09-28 2024-01-30 武汉大学人民医院（湖北省人民医院） 司美格鲁肽在制备预防或治疗心肌重构的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005535569A (ja) 2002-04-04 2005-11-24 ノボ・ノルデイスク・エー／エス Ｇｌｐ−１アゴニスト及び心臓血管合併症
TWI362392B (en) * 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
CN102946875A (zh) * 2010-05-05 2013-02-27 贝林格尔.英格海姆国际有限公司 组合疗法
EP3326620B1 (en) * 2010-12-16 2020-03-04 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2- hydroxybenzoyl)amino)caprylic acid
US20130035281A1 (en) 2011-02-09 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
EP2753642B8 (en) * 2011-09-06 2017-12-13 Novo Nordisk A/S Glp-1 derivatives
CA2929672A1 (en) * 2013-11-15 2015-05-21 Novo Nordisk A/S Selective pyy compounds and uses thereof
JP7221694B2 (ja) 2016-04-28 2023-02-14 ノヴォ ノルディスク アー／エス 心血管状態におけるセマグルチド

Also Published As

Publication number Publication date
AU2017256774B2 (en) 2024-07-11
SI3448416T1 (sl) 2022-10-28
HUE060040T2 (hu) 2023-01-28
PL3448416T3 (pl) 2022-11-07
KR20250038818A (ko) 2025-03-19
WO2017186896A1 (en) 2017-11-02
CN109069589A (zh) 2018-12-21
MA44762A (fr) 2019-03-06
KR20220147712A (ko) 2022-11-03
KR102778218B1 (ko) 2025-03-10
RS63630B1 (sr) 2022-10-31
EP3448416B1 (en) 2022-08-10
US20190134162A1 (en) 2019-05-09
IL262390A (en) 2018-12-31
MY202967A (en) 2024-05-31
KR20180135012A (ko) 2018-12-19
PH12018502274A1 (en) 2019-09-09
HRP20221150T1 (hr) 2022-11-25
PH12018502274B1 (en) 2024-02-28
AU2017256774A1 (en) 2018-11-01
RU2018140900A3 (da) 2020-09-28
CA3022535A1 (en) 2017-11-02
JP7221694B2 (ja) 2023-02-14
ES2928007T3 (es) 2022-11-14
EP3448416A1 (en) 2019-03-06
IL262390B1 (en) 2023-05-01
RU2018140900A (ru) 2020-05-28
MX2018012700A (es) 2019-01-30
CL2018003045A1 (es) 2018-12-14
CN109069589B (zh) 2022-09-06
BR112018072020A2 (pt) 2019-02-12
JP2019514925A (ja) 2019-06-06
AU2024227113A1 (en) 2024-10-31
RU2768283C2 (ru) 2022-03-23

Similar Documents

Publication Publication Date Title
EP3374114A4 (en) WORKBENCH
DK3277719T3 (da) Polypeptider
DK3305788T3 (da) Janus-kinase-hæmmer
DK3331528T3 (da) Muskarinagonister
DK3448416T3 (da) Semaglutid ved kardiovaskulære tilstande
DK3310450T3 (da) Olie-vand-separator
DK3242685T3 (da) Cxcr4-bindende molekyler
EP3378606A4 (en) ASSISTANCE COMBINATION
EP3341259A4 (en) WHEELBARROW
DK3270930T3 (da) Præeklampsi
DK3551355T3 (da) Immobiliseret indsats
DK3292136T3 (da) Penicillin-g-acylaser
DE112015006486A5 (de) Inkubationsrinne
DE112016001806A5 (de) Bausatz
DK3253755T3 (da) Hidtil ukendte cyclopropabenzofuranyl-pyridopyrazindioner
DK3274482T3 (da) Stenborsknop
DK3318308T3 (da) Badmintonketsjer
DK3423082T3 (da) Liraglutid ved kardiovaskulære tilstande
DE112015005906A5 (de) Gurtschlossbringer
DE112016005599A5 (de) Strahlungsgrill
DE102015206660A8 (de) Plattenaufteilanlage
UY4439S (es) Trofeo
DE102015000551A8 (de) Rotationszerstäuberturbine
DK3334807T3 (da) Ildtænder
DE112016001124A5 (de) Spannschutz